ANGPTL4 & Adipose RNA Update — Monday May 18, 2026

This week's literature shows ANGPTL4 emerging as a multi-context tumor suppressor in head and neck cancer and a ferroptosis regulator in lung injury, while Mendelian randomization studies strengthen its causal standing in metabolic-cardiovascular disease; LNP delivery science advances on bone-marrow and lung-tumor fronts but adipose-selective RNA targeting remains an active gap.

Episode metadata supplied by the publisher feed · Published May 18, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

ANGPTL4 & Adipose RNA Update — Monday May 18, 2026

0:00 7:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ANGPTL4 & Adipose RNA Update?

This episode is 7 minutes long.

When was this ANGPTL4 & Adipose RNA Update episode published?

This episode was published on May 18, 2026.

Can I download this ANGPTL4 & Adipose RNA Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!